CorMedix (CRMD) Return on Equity (2011 - 2025)

CorMedix has disclosed Return on Equity across 13 years of filings, most recently posting 0.0% for Q4 2025.

• Return on Equity for Q4 2025 came in at 0.0%, changed 0.0% year-over-year; the trailing twelve-month figure through Dec 2025 was 0.0% (changed 0.0% YoY), and the FY2025 annual result was 0.01%, up 1.0% from the prior year.
• Return on Equity came in at 0.0% for Q4 2025 at CorMedix, down from 0.01% in the prior quarter.
• In the past five years, Return on Equity ranged from a high of 0.01% in Q3 2025 to a low of 0.01% in Q2 2024.
• The 5-year median for Return on Equity is 0.01% (2022), against an average of 0.0%.
• Across the five-year window, Return on Equity changed 0 bps in 2021 and grew 1 bps in 2024, its largest moves.
• CorMedix's Return on Equity stood at 0.0% in 2021, then retreated by 17 bps to 0.01% in 2022, then dropped by 12 bps to 0.01% in 2023, then soared by 103 bps to 0.0% in 2024, then surged by 2540 bps to 0.0% in 2025.
• The last three Return on Equity figures came in at 0.0% (Q4 2025), 0.01% (Q3 2025), and 0.0% (Q2 2025), per Business Quant data.